CONSIDERATIONS TO KNOW ABOUT NEMBUTAL DRUG

Monitor Closely (2)pentobarbital will lessen the extent or impact of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Powerful CYP3A4 inducers may well decrease suvorexant efficacy; if improved suvorexant dose expected, don't exceed twenty mg/daypentobarbital will lessen the level or effect of buprenorphine